MECHANISMS OF HEPATOCARCINOGENICITY OF PEROXISOME-PROLIFERATING DRUGSAND CHEMICALS

Authors
Citation
Bg. Lake, MECHANISMS OF HEPATOCARCINOGENICITY OF PEROXISOME-PROLIFERATING DRUGSAND CHEMICALS, Annual review of pharmacology and toxicology, 35, 1995, pp. 483-507
Citations number
155
Categorie Soggetti
Toxicology,"Pharmacology & Pharmacy
ISSN journal
03621642
Volume
35
Year of publication
1995
Pages
483 - 507
Database
ISI
SICI code
0362-1642(1995)35:<483:MOHOPD>2.0.ZU;2-6
Abstract
A wide variety of chemicals have been shown to produce liver enlargeme nt, peroxisome proliferation, and induction of peroxisomal and microso mal fatty acid-oxidizing enzyme activities in rats and mice. Moreover, certain peroxisome proliferators have been shown to increase the inci dence of liver tumors in these two species. This review describes the characteristics of peroxisome proliferation in rodent liver and in vit ro in primary hepatocyte cultures and gives examples of the range of d ifferent classes of chemicals that produce this effect. Mechanisms of initiation of peroxisome proliferation in rodent hepatocytes, includin g peroxisome proliferator-activated receptors, are also described. Per oxisome proliferators are not considered to be genotoxic carcinogens, and proposed mechanisms of liver tumor formation include induction of sustained oxidative stress, a role for enhanced cell replication, and the promotion of spontaneous preneoplastic lesions. Data are also pres ented on species differences in response and key issues concerning the risk assessment to humans of rodent liver peroxisome proliferators.